Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems long and uncertain, according to a news release.

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...